Dickson native Dr. Gregory Gerdeman, Ph.D., has been named Chief Scientific Officer for the United Cannabis Corp., headquartered in Golden, Colo.
Gerdeman’s primary focus will be supporting the company’s research efforts and expanding its A.C.T. Now Program.
Gerdeman is one of the country’s foremost authorities on the physiological actions of medical cannabis and the endocannabinoid system. His work over two decades has been funded by the National Institute on Drug Abuse and National Science Foundation, and earned multiple awards for excellence from the International Cannabinoid Research Society.
His doctoral dissertation in pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as “retrograde messengers” that regulate synaptic plasticity in the brain.
“The science around cannabis is diverse and fast-paced,” Gerdeman said. “As part of United Cannabis, I have the opportunity to work with an outstanding team, and to pragmatically apply the knowledge and expertise I’ve gained in both academia and the industry, to advance the use of cannabis for patient care and wellness around the world.”
Gerdeman’s papers have appeared in top-tier scientific journals including “Nature Neuroscience” and “Trends in Neuroscience” and have been cited well over 2,000 times in scientific literature.
Prior to joining United Cannabis, Gerdeman served as Chief Scientific Officer for 3 Boys Farm, a vertically integrated cannabis company in Florida. From 2008 to 2017 he was assistant professor of biology at Eckerd College.